Grifols Plans $210M Expansion, 250 New Jobs in Johnston County

CLAYTON, N.C. -- Grifols, one of the world’s leading manufacturers of plasma-based medicines, plans to invest $210 million in two expansion projects at its existing site in Clayton. The projects, expected to create 250 new jobs in Johnston County, are part of $360 million the Spain-based company is spending on facilities in North Carolina, Ireland and Spain to expand its manufacturing capacity to meet global demand for its medicines through 2030, according to a company news release.



Innovative Public Relations - Relentless Innovation. Proven Results.
Giving You An Unfair Advantage
One of the projects in Clayton will build a 100,000-square-foot plasma fractionation facility, with construction to begin the first quarter of 2017 and production to start in 2022. Plasma fractionation is the process of separating from plasma the components that contain proteins with therapeutic uses. These components are then purified and sterilized in specific plants for each of the proteins obtained.

The second project in Clayton will be a 120,000-square-foot purification facility for the production of intravenous immunoglobulin. It is scheduled for completion in late 2021.

The Johnston County Board of Commissioners has approved an incentive package of up to $12.7 million over 10 years for the projects. The county will grant Grifols up to $1.27 million annually over the next decade if it meets its projections for investments and job creation. The grants will come in the form of reimbursements of portions of Grifols’ real estate and property taxes.

Barcelona-based Grifols is present in more than 100 countries worldwide. It is a leader in plasma collection, with a network of 150 plasma donor centers in the U.S., and a leading producer of plasma-derived biological medicines.

Grifols is part of North Carolina’s world-class life science industry. The state is home to more than 600 life science companies, including leaders such as Biogen, Bayer Crop Science, Merck, Pfizer, PPD and Quintiles to name a few. Nearly 61,000 highly skilled employees work at the 1,500 life science establishments across the state.